ZHANG Yue
Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease & Fu Wai Hospital & National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaXU Ruixia
Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease & Fu Wai Hospital & National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaZHANG Yan
Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease & Fu Wai Hospital & National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaWU Yaru
Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease & Fu Wai Hospital & National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaLI Jianjun
Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease & Fu Wai Hospital & National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaDivision of Dyslipidemia, State Key Laboratory of Cardiovascular Disease & Fu Wai Hospital & National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China)
R5
ZHANG Yue, XU Ruixia, ZHANG Yan, WU Yaru, LI Jianjun. Effects of Xuezhikang on low-density lipoprotein subfractions and oxidized LDL in patients with hyperlipidemia[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(3):229-232.
Copy